Test-retest properties of [11C]PXT012253 as a positron emission tomography (PET) radiotracer in healthy human brain: PET imaging of mGlu4

Background The metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia. [ 11 C]PXT012253 is a PET radioligand for mGlu4 (3.4 nM), previously characterized in non-human primates. We aimed to determine the optimal method fo...

Full description

Saved in:
Bibliographic Details
Published inEJNMMI research Vol. 15; no. 1; pp. 71 - 10
Main Authors Stenkrona, Per, Arakawa, Ryosuke, Guo, Jiamei, Bang-Andersen, Benny, Nag, Sangram, Moein, Mohammad Mahdi, Jia, Zhisheng, Cselenyi, Zsolt, Halldin, Christer, Varrone, Andrea
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 14.06.2025
Springer Nature B.V
SpringerOpen
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background The metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia. [ 11 C]PXT012253 is a PET radioligand for mGlu4 (3.4 nM), previously characterized in non-human primates. We aimed to determine the optimal method for quantification, duration for acquisition, and test-retest reliability of the binding parameters for [ 11 C]PXT012253 in healthy volunteers. Results Six subjects (4 females) completed. [ 11 C]PXT012253 displayed high uptake and rapid wash-out. Unchanged [ 11 C]PXT012253 at 20 min was 10–20%. V T in subcortical regions was higher than in cortical regions. 2TC provided better fits than 1TC. V T by Logan GA and MA1 analysis correlated with that of 2TC-CM. MA1 showed better identifiability and standard error than Logan. The test-retest metrics in pons, putamen and thalamus showed absolute variability of V T <7% and ICC > 0.93 using the 2TC, Logan and MA1 graphical analyses. Time stability analysis showed that V T values estimated using 63 min of imaging were within 10% of the values obtained with 93 min with all three models. Conclusion [ 11 C]PXT012253 showed a high brain uptake, with rapid washout and metabolism. V T was reliably estimated using 2TC, Logan GA and MA1. The test-retest metrics showed high repeatability, indicating [ 11 C]PXT012253 to be a suitable PET radioligand for mGlu4.
AbstractList BackgroundThe metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia. [11C]PXT012253 is a PET radioligand for mGlu4 (3.4 nM), previously characterized in non-human primates. We aimed to determine the optimal method for quantification, duration for acquisition, and test-retest reliability of the binding parameters for [11C]PXT012253 in healthy volunteers.ResultsSix subjects (4 females) completed. [11C]PXT012253 displayed high uptake and rapid wash-out. Unchanged [11C]PXT012253 at 20 min was 10–20%. VT in subcortical regions was higher than in cortical regions. 2TC provided better fits than 1TC. VT by Logan GA and MA1 analysis correlated with that of 2TC-CM. MA1 showed better identifiability and standard error than Logan. The test-retest metrics in pons, putamen and thalamus showed absolute variability of VT<7% and ICC > 0.93 using the 2TC, Logan and MA1 graphical analyses. Time stability analysis showed that VT values estimated using 63 min of imaging were within 10% of the values obtained with 93 min with all three models.Conclusion[11C]PXT012253 showed a high brain uptake, with rapid washout and metabolism. VT was reliably estimated using 2TC, Logan GA and MA1. The test-retest metrics showed high repeatability, indicating [11C]PXT012253 to be a suitable PET radioligand for mGlu4.
Background The metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia. [ 11 C]PXT012253 is a PET radioligand for mGlu4 (3.4 nM), previously characterized in non-human primates. We aimed to determine the optimal method for quantification, duration for acquisition, and test-retest reliability of the binding parameters for [ 11 C]PXT012253 in healthy volunteers. Results Six subjects (4 females) completed. [ 11 C]PXT012253 displayed high uptake and rapid wash-out. Unchanged [ 11 C]PXT012253 at 20 min was 10–20%. V T in subcortical regions was higher than in cortical regions. 2TC provided better fits than 1TC. V T by Logan GA and MA1 analysis correlated with that of 2TC-CM. MA1 showed better identifiability and standard error than Logan. The test-retest metrics in pons, putamen and thalamus showed absolute variability of V T <7% and ICC > 0.93 using the 2TC, Logan and MA1 graphical analyses. Time stability analysis showed that V T values estimated using 63 min of imaging were within 10% of the values obtained with 93 min with all three models. Conclusion [ 11 C]PXT012253 showed a high brain uptake, with rapid washout and metabolism. V T was reliably estimated using 2TC, Logan GA and MA1. The test-retest metrics showed high repeatability, indicating [ 11 C]PXT012253 to be a suitable PET radioligand for mGlu4.
Abstract Background The metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia. [11C]PXT012253 is a PET radioligand for mGlu4 (3.4 nM), previously characterized in non-human primates. We aimed to determine the optimal method for quantification, duration for acquisition, and test-retest reliability of the binding parameters for [11C]PXT012253 in healthy volunteers. Results Six subjects (4 females) completed. [11C]PXT012253 displayed high uptake and rapid wash-out. Unchanged [11C]PXT012253 at 20 min was 10–20%. V T in subcortical regions was higher than in cortical regions. 2TC provided better fits than 1TC. V T by Logan GA and MA1 analysis correlated with that of 2TC-CM. MA1 showed better identifiability and standard error than Logan. The test-retest metrics in pons, putamen and thalamus showed absolute variability of V T<7% and ICC > 0.93 using the 2TC, Logan and MA1 graphical analyses. Time stability analysis showed that V T values estimated using 63 min of imaging were within 10% of the values obtained with 93 min with all three models. Conclusion [11C]PXT012253 showed a high brain uptake, with rapid washout and metabolism. V T was reliably estimated using 2TC, Logan GA and MA1. The test-retest metrics showed high repeatability, indicating [11C]PXT012253 to be a suitable PET radioligand for mGlu4.
ArticleNumber 71
Author Jia, Zhisheng
Arakawa, Ryosuke
Moein, Mohammad Mahdi
Guo, Jiamei
Bang-Andersen, Benny
Stenkrona, Per
Nag, Sangram
Varrone, Andrea
Halldin, Christer
Cselenyi, Zsolt
Author_xml – sequence: 1
  givenname: Per
  orcidid: 0000-0002-5529-3336
  surname: Stenkrona
  fullname: Stenkrona, Per
  email: per.stenkrona@ki.se
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council
– sequence: 2
  givenname: Ryosuke
  surname: Arakawa
  fullname: Arakawa, Ryosuke
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council
– sequence: 3
  givenname: Jiamei
  surname: Guo
  fullname: Guo, Jiamei
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council, Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University
– sequence: 4
  givenname: Benny
  surname: Bang-Andersen
  fullname: Bang-Andersen, Benny
  organization: H. Lundbeck A/S
– sequence: 5
  givenname: Sangram
  surname: Nag
  fullname: Nag, Sangram
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council
– sequence: 6
  givenname: Mohammad Mahdi
  surname: Moein
  fullname: Moein, Mohammad Mahdi
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council
– sequence: 7
  givenname: Zhisheng
  surname: Jia
  fullname: Jia, Zhisheng
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council
– sequence: 8
  givenname: Zsolt
  surname: Cselenyi
  fullname: Cselenyi, Zsolt
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council
– sequence: 9
  givenname: Christer
  surname: Halldin
  fullname: Halldin, Christer
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council, Department of Biophysics and Radiation Biology, Semmelweis University HUN-REN TKI
– sequence: 10
  givenname: Andrea
  surname: Varrone
  fullname: Varrone, Andrea
  organization: Department of Clinical Neuroscience, Karolinska Institutet and Centre for Psychiatry Research, Stockholm County Council
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40515979$$D View this record in MEDLINE/PubMed
http://kipublications.ki.se/Default.aspx?queryparsed=id:162024881$$DView record from Swedish Publication Index
BookMark eNp9Uk1v1DAQjVARLaV_gAOyxAUOKR47dhIuCK1KqVSJHhapEkKWk0yyWTZ2amdB-xP410x3l9K94IM9mnnvzYfneXLkvMMkeQn8HKDQ7yJIpXjKhUo5CK3TzZPkREAJKV23R4_s4-QsxiWno0CVsniWHGdbMy9Pkt9zjFMacKKHjcGPGKYeI_Mt-wYw-35zOyd5oSSzkVk2-thPwTuGQx9jT8bkB98FOy427M3NxfwtC7bp_RRsjYH1ji3QriYKLtaDdawKtnfvGQFZP9iud919puFytc5eJE9bu4p4tn9Pk6-fLuazz-n1l8ur2cfrtFY6n1ItUFeNULyQhdCyqKtao20arXRTo2yqWkAh2rLVCC3IvEVJDFFmPKvzTObyNLna6TbeLs0YqI6wMd72ZuvwoTOWZlCv0JR5Q3SoGiiqTCu00tY1WFWVRaMQC9I632nFXziuqwO1vesHWWiAS5FzQYQPOwKFBqSCHU1qdcA7jLh-YTr_04AAnWcgSeH1XiH4uzX9mln6dXA0MSOp85yDAiDUq8d5HhL8_XgCiB2gDj7GgO0DBLi5XzCzWzBDC2a2C2Y2RJL7dgnsOgz_cv-H9QcAbdPn
Cites_doi 10.1080/13543776.2025.2467679
10.1177/0271678X16673646
10.1038/mp.2017.58
10.1186/s40673-018-0082-1
10.2967/jnumed.112.107995
10.1016/j.tet.2019.06.010
10.1146/annurev.pharmtox.011008.145533
10.1016/s0306-4522(01)00591-7
10.1016/j.neuropharm.2018.03.027
10.1097/01.WCB.0000038000.34930.4E
10.1007/s11307-018-1257-0
10.1002/mds.27462
10.1007/s00259-010-1447-8
10.1016/j.bmcl.2015.11.015
10.1021/jm501245b
10.1007/s00259-020-04739-5
10.1038/jcbfm.1990.127
10.1016/j.trac.2018.10.019
10.1002/brb3.1632
10.1007/s00259-015-3149-8
10.1080/13543784.2020.1839047
10.2174/1570159X17666191127112339
10.2967/jnumed.115.162461
10.1177/0271678X16668891
ContentType Journal Article
Copyright The Author(s) 2025
Copyright Springer Nature B.V. Dec 2025
The Author(s) 2025 2025
Copyright_xml – notice: The Author(s) 2025
– notice: Copyright Springer Nature B.V. Dec 2025
– notice: The Author(s) 2025 2025
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
8AO
8FE
8FG
8FI
8FJ
8FK
ABUWG
AFKRA
ARAPS
AZQEC
BENPR
BGLVJ
CCPQU
DWQXO
FYUFA
GHDGH
HCIFZ
K9.
M0S
P5Z
P62
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
5PM
ADTPV
AOWAS
D8T
ZZAVC
DOA
DOI 10.1186/s13550-025-01266-y
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Technology Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
SwePub
SwePub Articles
SWEPUB Freely available online
SwePub Articles full text
DOAJ Open Access Full Text
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
Advanced Technologies & Aerospace Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Advanced Technologies & Aerospace Database
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
DatabaseTitleList Publicly Available Content Database


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2191-219X
EndPage 10
ExternalDocumentID oai_doaj_org_article_97dfe31bd18b465ea3acc1a5b98d5ee8
oai_swepub_ki_se_1032702
PMC12167413
40515979
10_1186_s13550_025_01266_y
Genre Journal Article
GrantInformation_xml – fundername: Karolinska Institute
GroupedDBID 0R~
40G
53G
5VS
7X7
8AO
8FE
8FG
8FI
8FJ
AAFWJ
AAJSJ
AAKKN
AASML
ABDBF
ABEEZ
ABUWG
ACACY
ACGFS
ACIHN
ACUHS
ACULB
ADBBV
AEAQA
AENEX
AFGXO
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
ARAPS
BAPOH
BCNDV
BENPR
BFQNJ
BGLVJ
BPHCQ
BVXVI
C24
C6C
CCPQU
EBLON
EBS
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
HZ~
IAO
IHR
ITC
KQ8
M~E
OK1
P62
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RBZ
RNS
RPM
SMD
SOJ
U2A
UKHRP
AAYXX
CITATION
PQGLB
NPM
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
5PM
2VQ
4.4
ADRAZ
ADTPV
AHSBF
AOWAS
D8T
EJD
H13
M48
O9-
PUEGO
ZZAVC
ID FETCH-LOGICAL-c567t-62e6bd2508382638cbc6eadd656dce3dbc2182f9f6e1f137fe32e629404c74373
IEDL.DBID C24
ISSN 2191-219X
IngestDate Wed Aug 27 01:17:55 EDT 2025
Mon Aug 25 03:36:18 EDT 2025
Thu Aug 21 18:27:54 EDT 2025
Fri Jul 25 09:24:26 EDT 2025
Sat Jul 12 03:27:43 EDT 2025
Thu Jul 17 06:05:33 EDT 2025
Sun Jun 15 01:14:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Test-retest
C]PXT012253
mGlu4
Human brain
Positron emission tomography (PET)
[
[11C]PXT012253
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c567t-62e6bd2508382638cbc6eadd656dce3dbc2182f9f6e1f137fe32e629404c74373
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0002-5529-3336
OpenAccessLink https://link.springer.com/10.1186/s13550-025-01266-y
PMID 40515979
PQID 3218701511
PQPubID 2034773
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_97dfe31bd18b465ea3acc1a5b98d5ee8
swepub_primary_oai_swepub_ki_se_1032702
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12167413
proquest_journals_3218701511
pubmed_primary_40515979
crossref_primary_10_1186_s13550_025_01266_y
springer_journals_10_1186_s13550_025_01266_y
PublicationCentury 2000
PublicationDate 2025-06-14
PublicationDateYYYYMMDD 2025-06-14
PublicationDate_xml – month: 06
  year: 2025
  text: 2025-06-14
  day: 14
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle EJNMMI research
PublicationTitleAbbrev EJNMMI Res
PublicationTitleAlternate EJNMMI Res
PublicationYear 2025
Publisher Springer Berlin Heidelberg
Springer Nature B.V
SpringerOpen
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
– name: SpringerOpen
References C DeLorenzo (1266_CR11) 2017; 37
J Wang (1266_CR17) 2019; 75
KE Kil (1266_CR16) 2016; 26
I Esterlis (1266_CR15) 2018; 23
K Collste (1266_CR25) 2016; 43
D Doller (1266_CR7) 2020; 29
1266_CR19
J Logan (1266_CR20) 1990; 10
1266_CR4
P Zanotti-Fregonara (1266_CR8) 2016; 57
CM Niswender (1266_CR2) 2010; 50
SH Fatemi (1266_CR12) 2018; 5
C Corti (1266_CR3) 2002; 110
1266_CR23
G Olivero (1266_CR1) 2020; 18
R Arakawa (1266_CR24) 2020; 47
TG Lohith (1266_CR10) 2017; 37
Y Kimura (1266_CR9) 2010; 37
KE Kil (1266_CR22) 2014; 57
D Charvin (1266_CR6) 2018; 33
DF Wong (1266_CR13) 2013; 54
V Treyer (1266_CR14) 2020; 10
A Takano (1266_CR18) 2019; 21
D Charvin (1266_CR5) 2018; 135
M Ichise (1266_CR21) 2002; 22
References_xml – ident: 1266_CR4
  doi: 10.1080/13543776.2025.2467679
– volume: 37
  start-page: 2716
  year: 2017
  ident: 1266_CR11
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1177/0271678X16673646
– volume: 23
  start-page: 824
  year: 2018
  ident: 1266_CR15
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2017.58
– volume: 5
  start-page: 3
  year: 2018
  ident: 1266_CR12
  publication-title: Cerebellum Ataxias
  doi: 10.1186/s40673-018-0082-1
– volume: 54
  start-page: 388
  year: 2013
  ident: 1266_CR13
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.112.107995
– volume: 75
  start-page: 3917
  year: 2019
  ident: 1266_CR17
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2019.06.010
– ident: 1266_CR23
– volume: 50
  start-page: 295
  year: 2010
  ident: 1266_CR2
  publication-title: Annu Rev Pharmacol Toxicol
  doi: 10.1146/annurev.pharmtox.011008.145533
– volume: 110
  start-page: 403
  year: 2002
  ident: 1266_CR3
  publication-title: Neuroscience
  doi: 10.1016/s0306-4522(01)00591-7
– volume: 135
  start-page: 308
  year: 2018
  ident: 1266_CR5
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2018.03.027
– volume: 22
  start-page: 1271
  year: 2002
  ident: 1266_CR21
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1097/01.WCB.0000038000.34930.4E
– volume: 21
  start-page: 500
  year: 2019
  ident: 1266_CR18
  publication-title: Mol Imaging Biol
  doi: 10.1007/s11307-018-1257-0
– volume: 33
  start-page: 1619
  year: 2018
  ident: 1266_CR6
  publication-title: Mov Disord
  doi: 10.1002/mds.27462
– volume: 37
  start-page: 1943
  year: 2010
  ident: 1266_CR9
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-010-1447-8
– volume: 26
  start-page: 133
  year: 2016
  ident: 1266_CR16
  publication-title: Bioorg Med Chem Lett
  doi: 10.1016/j.bmcl.2015.11.015
– volume: 57
  start-page: 9130
  year: 2014
  ident: 1266_CR22
  publication-title: J Med Chem
  doi: 10.1021/jm501245b
– volume: 47
  start-page: 2429
  year: 2020
  ident: 1266_CR24
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-020-04739-5
– volume: 10
  start-page: 740
  year: 1990
  ident: 1266_CR20
  publication-title: J Cereb Blood Flow Metabolism
  doi: 10.1038/jcbfm.1990.127
– ident: 1266_CR19
  doi: 10.1016/j.trac.2018.10.019
– volume: 10
  start-page: e01632
  year: 2020
  ident: 1266_CR14
  publication-title: Brain Behav
  doi: 10.1002/brb3.1632
– volume: 43
  start-page: 173
  year: 2016
  ident: 1266_CR25
  publication-title: Eur J Nucl Med Mol Imaging
  doi: 10.1007/s00259-015-3149-8
– volume: 29
  start-page: 1323
  year: 2020
  ident: 1266_CR7
  publication-title: Expert Opin Investig Drugs
  doi: 10.1080/13543784.2020.1839047
– volume: 18
  start-page: 655
  year: 2020
  ident: 1266_CR1
  publication-title: Curr Neuropharmacol
  doi: 10.2174/1570159X17666191127112339
– volume: 57
  start-page: 242
  year: 2016
  ident: 1266_CR8
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.115.162461
– volume: 37
  start-page: 2458
  year: 2017
  ident: 1266_CR10
  publication-title: J Cereb Blood Flow Metab
  doi: 10.1177/0271678X16668891
SSID ssj0000515938
Score 2.3365073
Snippet Background The metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia. [ 11...
BackgroundThe metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia....
Abstract Background The metabotropic glutamate receptor 4 (mGlu4) has been proposed as a target for Parkinson’s disease to measure levodopa-induced dyskinesia....
SourceID doaj
swepub
pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 71
SubjectTerms [11C]PXT012253
Brain
Brain research
Cardiac Imaging
Catheters
Dyskinesia
Ethics
Human brain
Imaging
Ligands
Medical imaging
Medicine
Medicine & Public Health
mGlu4
Nuclear Medicine
Oncology
Original Research
Orthopedics
Parkinson's disease
Positron emission
Positron emission tomography (PET)
Radioactive tracers
Radiology
Schizophrenia
Stability analysis
Standard error
Test-retest
Thalamus
Tomography
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k2gIB-QAIHVdfyIww2qlgqpqIettBJCVvyIWMEmVTY97E_gXzPjZJcGEFy4RY6jsf2N45mx_Q0hz1SpfPC1Y9JzcFAw0ORc7lnuXY3se9Kl7A2nH_XJufywUIsrqb7wTNhADzwM3EFZhDoK7gI3TmoVK1F5zyvlShNUjOmaL6x5V5ypkdVblcJsb8kYfbDmsLLOGGZvhX-y1mwzWYkSYf-frMzfD0vudkx_YRdNK9LxLXJzNCXp26ELt8m12Nwh10_HzfK75PscJLAOI6s9vcCge4fsqbSt6SfODz-fLea446UErda0oun4Vtc2FDPAYQyN9u1qJLSmL86O5i9pV4VlC83zsaPLhg53KDc05fmjDpNNvKFQkS5XKfcRSlq9_3Yp75Hz46P54QkbMy8wr3TRM51H7UKOVPHgfgjjndegcgGMPxgHEZxH4ve6rHXkNRcFIARf5KWcSV8gWdJ9ste0TXxIaAADKxpRGw-mWwHOV1XhX0J7QNSDc5mRV1sU7MVAsGGTY2K0HTCzgJlNmNlNRt4hULuaSI6dCkBl7Kgy9l8qk5H9Lcx2nLFrK6BHBdhGnGfkwYD4TopM6lRAW81EFybNmL5pll8SVzfP8ZoHFxl5vVWbnzL_1s_ng2pNRIxFX-EpWmRCLGb5o_8xIo_JjTzNDM243Cd7fXcZn4Cx1bunaV79AAbKJ4o
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1baxQxFA5aQXwp3p1aJQ-CioZu5pJkfBEtrUWo9GELCyJhcpm66M6ss9OH_Qn-a8_JZLeMSt-GuXCSOSc5lyTfR8iLoiyss7VhueWQoGChyZjUstSaGtH3chPYG06_iJPz_POsmMWC2ypuq9zMiWGidq3FGvlBBr5Igu_i_P3yF0PWKFxdjRQaN8kthC5Dq5Yzua2xIH9JmanNWRklDlYc_OuEIYcrzMxCsPXIHwXY_v_Fmv9umdyum_6FMRr80vFdshsDSvphsIB75IZv7pPbp3HJ_AH5PQUJrMP6ak-XWHrvEEOVtjX9yvnht7PZFNe9ioxWK1rRsImraxuKPHBYSaN9u4iw1vTV2dH0Ne0qN2-hedZ3dN7Q4STlmga2P2qQcuIdhRfpfBEYkFDS4tPPy_whOT8-mh6esMi_wGwhZM9E6oVxKQLGQxKSKWusAMNzEALCf8icsQj_Xpe18Lzmmax9Bl-kZT7JrUTIpEdkp2kb_4RQB2GWV1mtLARwElKwqsK5QljjuIUUMyFvNlrQywFmQ4f0RAk96EyDznTQmV4n5CMqavsmQmSHG213oeOI06V00CAOApTJReGrrLKWV4UplSu8VwnZ36hZx3G70ldWlpDHg8a3UvJgThLaqka2MGrG-Ekz_x4Qu3mKhz14lpC3G7O5knldP18OpjUSEW_9gCuvEQ9RTtK96zvzlNxJg80LxvN9stN3l_4ZBFO9eR5GzB8clR1Q
  priority: 102
  providerName: ProQuest
Title Test-retest properties of [11C]PXT012253 as a positron emission tomography (PET) radiotracer in healthy human brain: PET imaging of mGlu4
URI https://link.springer.com/article/10.1186/s13550-025-01266-y
https://www.ncbi.nlm.nih.gov/pubmed/40515979
https://www.proquest.com/docview/3218701511
https://pubmed.ncbi.nlm.nih.gov/PMC12167413
http://kipublications.ki.se/Default.aspx?queryparsed=id:162024881
https://doaj.org/article/97dfe31bd18b465ea3acc1a5b98d5ee8
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9QwEA_eHYgv4rfVc8mDoKLFTdukqW-3y-4dwh3LsQuLIqFJU11026Pbe9g_wf_amTRdWT0EX0Lp16SdmWRmkvkNIS95xk1hSh0mhoGDgoEmrSMTRkaXiL6XaFe94fxCnC2Sj0u-9Elhm363e78k6UZqp9ZSvN8wmBqHIZZfhUFViHB7QI44-u64ROtzHDyiN89i2WfI3Pjo3izkwPpvsjD_3ii5Wy39A1nUzUbTe-SuNyPpScf3--SWrR6Q2-d-ofwh-TkHCmGDUdWWXmHAvUHkVFqX9DNj4y-z5RxXu3hM8w3Nqdu61dQVxepvGD-jbb32YNb09Wwyf0ObvFjV0D1jG7qqaJc_uaWuxh_VWGjiA4Ub6Wrt6h4hpfXpj-vkEVlMJ_PxWeirLoSGi7QNRWSFLiKEiQfXI5ZGGwHiVoDhB_8hLrRB0PcyK4VlJYvT0sbwRJQlw8SkCJT0mBxWdWWfElqAcWVlXEoDZlsKjlee4wghjC6YAccyIG97LqirDlxDOadECtXxTAHPlOOZ2gZkhIza3YnA2O5E3XxVXs9UlhbQIQYEpE4Et3mcG8NyrjNZcGtlQI57NiuvrRsVwxelYBcxFpAnHcd3VBInTin0Ve7Jwl439q9Uq28Op5tFmOLB4oC868XmN81_feerTrT2SPhT3-HIKkRBTIfRs_978XNyJ3I6IEKWHJPDtrm2L8CkavWAHCTDU2jTZQqtnMLx0WhyMbscON3CVowHLmAB7eXoE7SL6OQXSp8inw
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLbGkIAXxH2FAX4AAYJodZw4CRJCMNZ1bJ32kEmVEPLiS6CCJiXthPoT-DP8Rs5xkk4BtLe9VWna4-Qc-1zs832EPAmTUBudKy_QDBIULDQp5WvP1ypH9L1AOfaG0aEYHgcfx-F4jfxue2HwWGW7JrqF2pQaa-RbHHxRBL6LsbezHx6yRuHuakuhUZvFvl3-hJRt_mbvA-j3qe8PdtLtodewCng6FNHCE74VyvgIgw6hNY-10gJep4HAxmjLjdIIap4nubAsZzzKLYdf-EnQD3SEQEDwv5fI5YCDJ8fO9MHuqqaDfCkJj9venFhszRn4876HnLHgCYTwlh3_52gC_hfb_ntEc7VP-xemqfODgxvkehPA0ne1xd0ka7a4Ra6Mmi362-RXChK8Cuu5CzrDUn-FmK20zOknxrY_H41T3GcLOc3mNKPu0FhVFhR557ByRxfltIHRps-PdtIXtMrMpIThaVvRSUHrzs0ldeyCVCHFxWsKN9LJ1DEuoaTp7vfT4A45vhDN3CXrRVnYDUINhHU25nmsIWCMIOXLMlybhFaGaUhpe-RlqwU5q2E9pEuHYiFrnUnQmXQ6k8seeY-KWt2JkNzuQll9kc0Ml0lkYEAMBMQqEKHNeKY1y0KVxCa0Nu6RzVbNslkn5vLMqnvkXq3xlZTAmVMEY407ttAZRvebYvLVIYQzH5tLGO-RV63ZnMk87zmf1abVEdFc-gafrET8xajv3z__YR6Tq8N0dCAP9g73H5BrvrN_4bFgk6wvqlP7EAK5hXrkZg8lJxc9Xf8A-t5aGg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJ028TNzJGOAHECCIWufiJEgIsa1lY6yqUCdVQsjEl0AFTUqaCfUn8Jf4dZzjJJ0KaG97i3I7Ts6xz8X29xHyKExCpVUm3UAxSFCw0CSlp1xPyQzR9wJp2RtOhvzwNHg3CScb5He7FwaXVbZjoh2odaGwRt71wRdF4LsY62bNsojRweD1_IeLDFI409rSadQmcmyWPyF9W7w6OgBdP_a8QX-8f-g2DAOuCnlUudwzXGoPIdEhzPZjJRWHX6shyNHK-FoqBDjPkowbljE_yowPT3hJ0AtUhKBA8N4rZDPCrKhDNvf6w9GHVYUH2VMSP2536sS8u2Dg3XsuMsiCX-DcXa55Q0sa8L9I998Fm6tZ278QTq1XHFwj2004S9_U9nedbJj8Btk6aSbsb5JfY5DglljdregcC_8lIrjSIqMfGdv_NJqMcdYt9Gm6oCm1S8jKIqfIQod1PFoVswZUmz4d9cfPaJnqaQHNU6ak05zW-ziX1HINUomEFy8p3EinM8u_hJJmb7-fBbfI6aXo5jbp5EVu7hKqIcgzsZ_FCsLHCBLANMWRiiupmYIE1yHPWy2IeQ3yIWxyFHNR60yAzoTVmVg6ZA8VtboTAbrtiaL8Ipr-LpJIQ4MYCIhlwEOT-qlSLA1lEuvQmNghu62aRTNqLMS5jTvkTq3xlZTAmlMEbY3XbGGtGetX8ulXixfOPNxqwnyHvGjN5lzmRd_5pDatNRHNqW9wZASiMUY9b-fij3lItqCrivdHw-N75KpnzZ-7LNglnao8M_chqqvkg6b7UPL5snvsH-1_X6w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Test-retest+properties+of+%5B11C%5DPXT012253+as+a+positron+emission+tomography+%28PET%29+radiotracer+in+healthy+human+brain%3A+PET+imaging+of+mGlu4&rft.jtitle=EJNMMI+research&rft.au=Stenkrona%2C+Per&rft.au=Arakawa%2C+Ryosuke&rft.au=Guo%2C+Jiamei&rft.au=Bang-Andersen%2C+Benny&rft.date=2025-06-14&rft.pub=Springer+Berlin+Heidelberg&rft.eissn=2191-219X&rft.volume=15&rft_id=info:doi/10.1186%2Fs13550-025-01266-y&rft_id=info%3Apmid%2F40515979&rft.externalDocID=PMC12167413
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2191-219X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2191-219X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2191-219X&client=summon